尼珀与罗奇印度合作,促进药学教育和AI及监管事务的研究. NIPER Raebareli partners with Roche India to boost pharma education and research in AI and regulatory affairs.

尼珀·雷巴利尔与罗奇医药公司合作,通过新的谅解备忘录加强制药教育和研究,重点关注监管事务,药物开发中的人工智能以及通过奖学金和教师计划向行业展示. NIPER Raebareli has partnered with Roche Pharma India through a new MoU to strengthen pharmaceutical education and research, focusing on regulatory affairs, AI in drug development, and industry exposure via scholarships and faculty programs. 印度政府官员在药品部与该国签署的协议, 为支持印度在生物制剂和人工智能领域获得专业知识以提升其全球生物制药地位. The agreement, signed at the Department of Pharmaceuticals with government officials present, supports India’s push for expertise in biologics and AI to enhance its global biopharma standing. 这与NIPER Mohali在2026年2月签署的类似协议相继, 反映了罗氏建立一个产业和学术生态系统的更广泛战略. This follows a similar February 2026 MoU with NIPER Mohali, reflecting Roche’s broader strategy to build an industry-academia ecosystem that develops skilled, future-ready professionals in India’s evolving healthcare sector.